Back to Feed
ClinicalTrials.gov|Clinical Trial
A Clinical Study Exploring the Safety, Efficacy and Cell Metabolic Kinetics of Universal Car-t Cell Injection in CD19 and / or CD20 Positive Relapsed / Refractory B-cell Acute Lymphoblastic Leukemia in Adolescents, Children and Adults
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Abstract
This study is a single arm, open label, dose exploring clinical trial to evaluate the safety, efficacy, cellular metabolic dynamics, and pharmacodynamics of ct1190b cells in relapsed / refractory B-cell acute lymphoblastic leukemia. Phase: EARLY_PHASE1 Status: RECRUITING Conditions: ALL (Acute B-Lymphoblastic Leukemia) Interventions: CT1190B cell injection
Keywords
ALL (Acute B-Lymphoblastic Leukemia)